No profile data available.
Nanobiotix S.a. (NBTX) is a healthcare company in the targeted healthcare equipment industry, based in Paris, France, with about 100 full-time employees.
It reported revenue of 29.64 million EUR for fiscal year 2025, and net income of -23.96 million EUR. Its market capitalization was $1.21 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs.
Nanobiotix reported 29.64 million EUR in revenue for fiscal year 2025.
$1.21 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Nolato AB (publ) (NLTBF), Alpha Tau Medical Ltd. (DRTS), Staar Surgical Company (STAA), Procept BioRobotics Corporation (PRCT).